Axsome settles Auvelity patent litigation with Teva, delaying a generic launch until 2038. Analysts see growth potential with Symbravo's migraine approval.

With the settlement, Teva will not market the Auvelity generic until September 30, 2038, Axsome said in a Monday press ...

Under the agreement, Axsome will grant Teva a license to sell its generic version of Auvelity beginning on or after March 31, 2039, if pediatric exclusivity is granted for Auvelity, or on or after ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key ...

Teva Pharma Industries Ltd ADR, Allergan PLC, Johnson & Johnson, CVS Health Corp. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com ...

We’ve rounded up all our favorite makers of bras, bralettes, and sleepwear in Vogue’s ultimate guide to the best lingerie brands—plus, where and how to shop them. Whether you’re getting ...

From the call, the analyst notes that feedback on Teva's/Sanofi's SNY anti-TL1A antagonist duvakitug, along with the broader anti-TL1A class, suggests these agents could play a significant role in ...

Highlights,Deckers Outdoor revises Q3 2025 earnings to $2.55 per share.,Revenue rises 20.1%, driven by UGG, HOKA, and Teva brands.,Institutional holdings surge, reflecting strong market ...

The best CBD brands have a positive reputation; all their products undergo third-party testing. They also offer a wide range of products and are very clear about dosage and ingredients.

Trust is a cornerstone of meaningful relationships. When dealing with businesses and brands, it's often the deciding factor that separates companies we rely on from the ones we don't. It's about ...

Sure, it’s incumbent on the best clothing brands for men to push the envelope to new limits, but before you get there, you need to start from square one. Even GQ editors had to master the ...